Attached files
| file | filename |
|---|---|
| EX-99.1 - EX-99.1 - HeartWare International, Inc. | d740605dex991.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d)
of the Securities Exchange Act of 1934
Date of report (date of earliest event reported): June 4, 2014
HEARTWARE INTERNATIONAL, INC.
(Exact name of registrant as specified in its charter)
| Delaware | 001-34256 | 26-3636023 | ||
| (State or other jurisdiction of incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
500 Old Connecticut Path
Framingham, MA 01701
(Address of principal executive offices)
Registrant’s telephone number, including area code:
508.739.0950
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 5.07 Submission of Matters to a Vote of Security Holders
On Wednesday, June 4, 2014, HeartWare International, Inc. held its Annual Meeting of Stockholders at its corporate headquarters in Framingham, Massachusetts. Each of the proposals put to a vote of stockholders, and as previously announced in the Notice of Meeting contained in the company’s Definitive Proxy Statement filed with the Securities and Exchange Commission on April 28, 2014, was approved as recommended by the Board.
The proposals voted upon by stockholders of the company were as follows:
| 1. | To elect Timothy Barberich, Charles Raymond Larkin, Jr. and Robert Thomas as Class III Directors to hold office until the company’s annual meeting of stockholders to be held in 2017 or until their successors are duly elected and qualified; |
| 2. | To ratify the appointment of Grant Thornton LLP as the company’s independent registered public accounting firm for the fiscal year ending December 31, 2014; and |
| 3. | To consider and act on an advisory vote to approve the compensation paid to certain executive officers. |
A tabular summary of the voting results is attached as an exhibit and is incorporated by reference into this Item 5.07.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
| Exhibit No. |
Description | |
| 99.1 | Tabular Summary of Voting Results from HeartWare’s June 4, 2014 Annual Meeting of Stockholders | |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| HeartWare International, Inc. | ||||||
| Date: June 9, 2014 | By: | /s/ Lawrence J. Knopf | ||||
| Name: Lawrence J. Knopf | ||||||
| Title: Senior Vice President, General Counsel and Secretary | ||||||
INDEX TO EXHIBITS
| Exhibit No. |
Description | |
| 99.1 | Tabular Summary of Voting Results from HeartWare’s June 4, 2014 Annual Meeting of Stockholders | |